Clinical Trial Update: Dendritic Cell Vaccination in Patients With Advanced Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating dendritic cell vaccination in patients with advanced melanoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dendritic cell vaccine

Snippet

Sponsor: University of Pennsylvania | Conditions: Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2024-12-24